NCT00006371View on ClinicalTrials.gov

"A Phase II Trial of Early Medical Adrenalectomy for D0.5 Prostate Cancer"

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2001

Study Completion Date

December 31, 2001

Conditions

Prostate Cancer

Interventions

DRUG

aminoglutethimide

DRUG

ketoconazole

DRUG

therapeutic hydrocortisone

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

Janssen Pharmaceuticals

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER